This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Hims & Hers Health Securities Fraud Lawsuits
Business class action lawsuit

Hims & Hers Health Securities Fraud Lawsuits

Analysis based on 55 articles · First reported Jun 26, 2025 · Last updated Aug 05, 2025

Sentiment
-70
Attention
4
Articles
55
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The multiple class-action lawsuits against Hims & Hers Health for alleged securities fraud have significantly impacted its stock price, which fell over 34%. This event highlights the risks associated with partnerships and regulatory compliance in the telehealth and pharmaceutical industries, potentially leading to increased scrutiny for similar companies.

Pharmaceuticals Telehealth Legal Services
Event Summary

Hims & Hers Health is facing multiple class-action lawsuits for alleged securities fraud, filed by law firms including Bleichmar Fonti & Auld LLP, Kessler Topaz Meltzer & Check, and Levi & Korsinsky. The lawsuits, pending in the United States — United States District Court for the Northern District of California, claim that Hims & Hers Health made false and misleading statements to investors regarding its partnership with Novo Nordisk and its compliance with FDA regulations concerning compounded semaglutide. The core of the allegations is that Hims & Hers Health deceptively promoted and sold 'illegitimate, knockoff versions of Wegovy,' which led to Novo Nordisk terminating their 'long-term collaboration' on June 23, 2025. Following this announcement, Hims & Hers Health's stock price plummeted by over 34%. Investors who purchased Hims & Hers Health securities between April 29, 2025, and June 23, 2025, have until August 25, 2025, to seek appointment as lead plaintiff in these lawsuits.

Key Actions
100 Bleichmar Fonti & Auld LLP filed lawsuit Hims & Hers Health
96 Novo Nordisk terminated partnership Hims & Hers Health
90 Hims & Hers Health engaged in promotion
85 Levi & Korsinsky notifies investors of lawsuit Hims & Hers Health
85 Kessler Topaz Meltzer & Check filed lawsuits Hims & Hers Health
80 Hims & Hers Health announced collaboration Novo Nordisk
75 Robbins Geller Rudman & Dowd LLP filed class action Hims & Hers Health
75 Faruqi & Faruqi investigated claims Hims & Hers Health
Entities Involved
stock
Hims & Hers Health
Hims & Hers Health is facing multiple class-action lawsuits for alleged securities fraud, stemming from its deceptive promotion of compounded semaglutide and the subsequent termination of its partnership with Novo Nordisk. Its stock price fell over 34% on the news.
Importance 100.0 Sentiment -80.0
stock
Novo Nordisk
Novo Nordisk terminated its partnership with Hims & Hers Health due to the latter's deceptive promotion of 'knockoff' versions of Wegovy, protecting its brand and patient safety.
Importance 90.0 Sentiment 20.0
priv
Bleichmar Fonti & Auld LLP
Bleichmar Fonti & Auld LLP is a leading securities law firm that filed a class-action lawsuit against Hims & Hers Health for alleged securities law violations.
Importance 70.0 Sentiment 10.0
priv
Kessler Topaz Meltzer & Check
Kessler Topaz Meltzer & Check is a law firm that has also filed a securities class action lawsuit against Hims & Hers Health.
Importance 60.0 Sentiment 10.0
govactor
United States — United States District Court for the Northern District of California
The United States — United States District Court for the Northern District of California is where the class-action lawsuits against Hims & Hers Health are pending.
Importance 60.0 Sentiment 0.0
priv
Robbins Geller Rudman & Dowd LLP
Robbins Geller Rudman & Dowd LLP announced that Hims & Hers Health investors have an opportunity to lead a securities class action lawsuit.
Importance 50.0 Sentiment 10.0
per
Jennifer N. Caringal
Jennifer N. Caringal is an attorney at Robbins Geller Rudman & Dowd LLP LLP, involved in the Hims & Hers Health class action lawsuit.
Importance 10.0 Sentiment 0.0
per
J. C. Sanchez
J. C. Sanchez is an attorney at Robbins Geller Rudman & Dowd LLP LLP, involved in the Hims & Hers Health class action lawsuit.
Importance 10.0 Sentiment 0.0
per
Jonathan Naji
Jonathan Naji is an attorney at Kessler Topaz Meltzer & Check, serving as a contact for investors regarding the class action lawsuits.
Importance 10.0 Sentiment 0.0
per
Joseph E. Levi
Importance 0.0 Sentiment 0.0
priv
Levi & Korsinsky
Importance 0.0 Sentiment 0.0
priv
Faruqi & Faruqi
Importance 0.0 Sentiment 0.0
per
James Wilson
Importance 0.0 Sentiment 0.0
Relationships
Hims & Hers Health competitor ↔ Novo Nordisk Hims & Hers Health is facing legal threats from Novo Nordisk after their brief distribution partnership was terminated o
Bleichmar Fonti & Auld LLP related ↔ United States — United States District Court for the Northern District of California
Bleichmar Fonti & Auld LLP related ↔ Robbins Geller Rudman & Dowd LLP
Kessler Topaz Meltzer & Check related ↔ United States — United States District Court for the Northern District of California
Kessler Topaz Meltzer & Check related ↔ Robbins Geller Rudman & Dowd LLP
Kessler Topaz Meltzer & Check related ↔ Jonathan Naji
Kessler Topaz Meltzer & Check related ↔ Joseph E. Levi
United States — United States District Court for the Northern District of California related ↔ Robbins Geller Rudman & Dowd LLP
United States — United States District Court for the Northern District of California related ↔ J. C. Sanchez
United States — United States District Court for the Northern District of California related ↔ Jonathan Naji
United States — United States District Court for the Northern District of California related ↔ Joseph E. Levi
Robbins Geller Rudman & Dowd LLP related ↔ Jennifer N. Caringal
Robbins Geller Rudman & Dowd LLP related ↔ J. C. Sanchez
Robbins Geller Rudman & Dowd LLP related ↔ Jonathan Naji
Robbins Geller Rudman & Dowd LLP related ↔ Joseph E. Levi
+ 4 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.